Clinical Trials Browser

Phase 2 × patritumab deruxtecan × CNS × Clear all

NCT05865990 2026-03-12

TUXEDO-3

Phase 2 Active not recruiting

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms

NCT05620914 2025-06-15

PARAMETer

Phase 2 Withdrawn

Brain Neoplasms